Literature DB >> 16289621

Comparison of opioid receptor distributions in the rat ileum.

A C Gray1, I M Coupar, P J White.   

Abstract

The cellular expression patterns of mu-, delta- and kappa-opioid receptors in the rat ileum were examined using fluorescence immunohistochemistry. Double-labelling was used to examine cellular receptor co-localisation as a pre-requisite for intracellular molecular interactions, such as heterodimerisation. Tissues were stained as whole-mount preparations. Strong, broadly distributed immunoreactivity (ir) was observed for each receptor in the myenteric and submucous plexuses. Although intracellular mu- and delta-ir patterns differed in ganglion neurons, mu/delta co-expression was extensive in these cells. mu/delta co-expression was also observed in interstitial cells, which were diffusely distributed in submucous plexus preparations but generally located adjacent to myenteric plexus structures. Punctate kappa-ir was seen broadly in nerve fibres in both plexuses, suggesting localisation in varicosities. Neuronal mu/kappa co-localisation was not apparent, although kappa-ir fibres were often apposed against mu-ir cells. mu/kappa co-localisation was detected in interstitial cells in submucous plexus preparations. Similarities in mu and delta expression patterns might reflect similar functional properties previously detected for these receptors. This study indicates that the rat gastrointestinal tract might provide a useful tool for the future study of molecular interactions between opioid receptor types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289621     DOI: 10.1016/j.lfs.2005.07.048

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice.

Authors:  Daniel P Poole; Juan-Carlos Pelayo; Gregory Scherrer; Christopher J Evans; Brigitte L Kieffer; Nigel W Bunnett
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

2.  Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist.

Authors:  P R Wade; J M Palmer; S McKenney; V Kenigs; K Chevalier; B A Moore; J R Mabus; P R Saunders; N H Wallace; C R Schneider; E S Kimball; H J Breslin; W He; P J Hornby
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

3.  Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.

Authors:  Wakako Fujita; Ivone Gomes; Leonard S Dove; David Prohaska; Gail McIntyre; Lakshmi A Devi
Journal:  Biochem Pharmacol       Date:  2014-09-28       Impact factor: 5.858

Review 4.  The Mechanisms Involved in Morphine Addiction: An Overview.

Authors:  Joanna Listos; Małgorzata Łupina; Sylwia Talarek; Antonina Mazur; Jolanta Orzelska-Górka; Jolanta Kotlińska
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

5.  Pharmacologic effects of naldemedine, a peripherally acting μ-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation.

Authors:  Toshiyuki Kanemasa; Katsumi Koike; Tohko Arai; Hiroko Ono; Narumi Horita; Hiroki Chiba; Atsushi Nakamura; Yasuhide Morioka; Tsuyoshi Kihara; Minoru Hasegawa
Journal:  Neurogastroenterol Motil       Date:  2019-02-28       Impact factor: 3.960

Review 6.  Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.

Authors:  Ewa Gibula-Tarlowska; Jolanta H Kotlinska
Journal:  Biomolecules       Date:  2020-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.